Cyclosporine a drives a Th17- and Th2-mediated posttransplant obliterative airway disease

American Journal of Transplantation

Volumn 13, Issue 3, 2013, Pages 611-620

  Lemaitre P H ^a   Vokaer, B ^a   Charbonnier, L M ^a   Iwakura, Y ^b   Field, K A ^c   Estenne, M ^d   Goldman, M ^e   Leo, O ^a   Remmelink, M ^d   Moine, A Le ^a,d  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY OF TOKYO   (Japan)

^c BUCKNELL UNIVERSITY   (United States)

^d ERASME HOSPITAL   (Belgium)

^e Innovative Medicines Initiative   (Belgium)

Author keywords

Bronchiolitis obliterans; cyclosporine A; obliterative airway disease; T cells; transplantation and immunology

Indexed keywords

CYCLOSPORIN A; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHIOLITIS OBLITERANS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FLOW CYTOMETRY; GRAFT RECIPIENT; IN VIVO STUDY; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH17 CELL; TH2 CELL; TRACHEA; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; BRONCHIOLITIS OBLITERANS; CYCLOSPORINE; CYTOKINES; FLOW CYTOMETRY; GRAFT REJECTION; IMMUNOENZYME TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-4; LUNG TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TH2 CELLS; TRACHEA; TRANSPLANTATION, HETEROTOPIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 84874429197     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12067     Document Type: Article

References (45)

1. Lodhi SA, Lamb KE, Meier-Kriesche HU,. Solid organ allograft survival improvement in the United States: The long-term does not mirror the dramatic short-term success. Am J Transplant 2011; 11: 1226-1235.
2. Keane MP, Gomperts BN, Weigt S, et al. IL-13 Is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome. J Immunol 2007; 178: 511-519.
3. Burlingham WJ, Love RB, Jankowska-Gan E, et al. IL-17-dependent cellular immunity to collagen type v predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 2007; 117: 3498-3506.
4. Vanaudenaerde BM, De Vleeschauwer SI, Vos R, et al. The role of the IL23/IL17 Axis in bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant 2008; 8: 1911-1920.
5. Snell GI, Levvey BJ, Zheng L, et al. Interleukin-17 and airway inflammation: A longitudinal airway biopsy study after lung transplantation. J Heart Lung Transplant 2007; 26: 669-674.
6. Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth adult lung and heart-lung transplant report-2011. J Heart Lung Transplant 2011; 30: 1104-1122.
7. Zand MS, Li Y, Hancock W, et al. Interleukin-2 and interferon-gamma double knockout mice reject heterotopic cardiac allografts. Transplantation 2000; 70: 1378-1381.
8. Sadlack B, Lohler J, Schorle H, Klebb G, et al. Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur J Immunol 1995; 25: 3053-3059.
9. Suzuki H, Kundig TM, Furlonger C, et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 1995; 268: 1472-1476.
10. Abadja F, Videcoq C, Alamartine E, Berthoux F, Mariat C,. Differential effect of cyclosporine and mycophenolic acid on the human regulatory T cells and TH-17 cells balance. Transplant Proc 2009; 41: 3367-3370.
11. Abadja F, Atemkeng S, Alamartine E, Berthoux F, Mariat C,. Impact of mycophenolic acid and tacrolimus on Th17-related immune response. Transplantation 2011; 92: 396-403.
12. Jiang H, Yang X, Soriano RN, Fujimura T, Krishnan K, Kobayashi M,. Distinct patterns of cytokine gene suppression by the equivalent effective doses of cyclosporine and tacrolimus in rat heart allografts. Immunobiology 2000; 202: 280-292.
13. Pacocha SE, Oriente A, Huang SK, Essayan DM,. Regulation of antigen-induced human T-lymphocyte responses by calcineurin antagonists. J Allergy Clin Immunol 1999; 104: 828-835.
14. Shimizu K, Fujii S, Fujimoto K, Kawa K, Yamada A, Kawano F,. Tacrolimus (FK506) treatment of CD34+ hematopoietic progenitor cells promote the development of dendritic cells that drive CD4+ T cells toward Th2 responses. J Leukoc Biol 2000; 68: 633-640.
15. Tsuda K, Yamanaka K, Kitagawa H, et al. Calcineurin inhibitors suppress cytokine production from memory T cells and differentiation of naive T cells into cytokine-producing mature T cells. PLoS One 2012; 7: e31465.
16. Zhang C, Zhang J, Yang B, Wu C,. Cyclosporin A inhibits the production of IL-17 by memory Th17 cells from healthy individuals and patients with rheumatoid arthritis. Cytokine 2008; 42: 345-352.
17. Frischbutter S, Gabriel C, Bendfeldt H, Radbruch A, Baumgrass R,. Dephosphorylation of Bcl-10 by calcineurin Is essential for canonical NF-KappaB activation in Th cells. Eur J Immunol 2011; 41: 2349-2357.
18. Sugimoto T, Stewart S, Guan KL,. The calcium/calmodulin-dependent protein phosphatase calcineurin is the major Elk-1 phosphatase. J Biol Chem 1997; 272: 29415-29418.
19. Halloran PF,. Mechanism of action of the calcineurin inhibitors. Transplant Proc 2001; 33: 3067-3069.
20. Hertz MI, Jessurun J, King MB, Savik SK, Murray JJ,. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. Am J Pathol 1993; 142: 1945-1951.
21. Kelly KE, Hertz MI, Mueller DL,. T cell and major histocompatibility complex requirements for obliterative airway disease in heterotopically transplanted murine tracheas. Transplantation 1998; 66: 764-771.
22. Higuchi T, Jaramillo A, Kaleem Z, Patterson GA, Mohanakumar T,. Different kinetics of obliterative airway disease development in heterotopic murine tracheal allografts induced by CD4+ and CD8+ T cells. Transplantation 2002; 74: 646-651.
23. Belperio JA, Keane MP, Burdick MD, et al. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol 2002; 169: 1037-1049.
24. Hong KU, Reynolds SD, Watkins S, Fuchs E, Stripp BR,. Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium. Am J Pathol 2004; 164: 577-588.
25. King MB, Jessurun J, Savik SK, Murray JJ, Hertz MI,. Cyclosporine reduces development of obliterative bronchiolitis in a murine heterotopic airway model. Transplantation 1997; 63: 528-532.
26. Auchincloss H, Jr., Winn HJ,. Murine CD8+ T cell helper function is particularly sensitive to cyclosporine suppression in vivo. J Immunol 1989; 143: 3940-3943.
27. Richards DM, Dalheimer SL, Hertz MI, Mueller DL,. Trachea allograft class I molecules directly activate and retain CD8+ T cells that cause obliterative airways disease. J Immunol 2003; 171: 6919-6928.
28. Le Moine A, Goldman M, Abramowicz D,. Multiple pathways to allograft rejection. Transplantation 2002; 73: 1373-1381.
29. Teixeira LK, Fonseca BP, Vieira-de-Abreu A, et al. IFN-gamma production by CD8+ T cells depends on NFAT1 transcription factor and regulates Th differentiation. J Immunol 2005; 175: 5931-5939.
30. Wynn TA,. Integrating mechanisms of pulmonary fibrosis. J Exp Med 2011; 208: 1339-1350.
31. Oldroyd SD, Thomas GL, Gabbiani G, El Nahas AM,. Interferon-gamma inhibits experimental renal fibrosis. Kidney Int 1999; 56: 2116-2127.
32. Chan SY, DeBruyne LA, Goodman RE, Eichwald EJ, Bishop DK,. In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection. Transplantation 1995; 59: 1155-1161.
33. Mele TS, Kneteman NM, Zhu LF, et al. IFN-gamma is an absolute requirement for spontaneous acceptance of liver allografts. Am J Transplant 2003; 3: 942-951.
34. Sawitzki B, Kingsley CI, Oliveira V, Karim M, Herber M, Wood KJ,. IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med 2005; 201: 1925-1935.
35. Besnard AG, Togbe D, Couillin I, et al. Inflammasome-IL-1-Th17 response in allergic lung inflammation. J Mol Cell Biol 2012; 4: 3-10.
36. Fukami N, Ramachandran S, Saini D, et al. Antibodies to MHC class I induce autoimmunity: Role in the pathogenesis of chronic rejection. J Immunol 2009; 182: 309-318.
37. Yoshida S, Haque A, Mizobuchi T, et al. Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants. Am J Transplant 2006; 6: 724-735.
38. Fernandez FG, Jaramillo A, Chen C, et al. Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease. Am J Transplant 2004; 4: 319-325.
39. Wynn TA,. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 2004; 4: 583-594.
40. Simonian PL, Roark CL, Born WK, O'Brien RL, Fontenot AP,. Gammadelta T cells and Th17 cytokines in hypersensitivity pneumonitis and lung fibrosis. Transl Res 2009; 154: 222-227.
41. Saito A, Okazaki H, Sugawara I, Yamamoto K, Takizawa H,. Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro. Int Arch Allergy Immunol 2003; 132: 168-176.
42. Booth AJ, Bishop DK,. TGF-beta, IL-6, IL-17 and CTGF direct multiple pathologies of chronic cardiac allograft rejection. Immunotherapy 2010; 2: 511-520.
43. Wang H, Hosiawa KA, Min W, et al. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting. J Immunol 2003; 171: 3823-3836.
44. Ropponen JO, Syrjala SO, Krebs R, Nykanen A, Tikkanen JM, Lemstrom KB,. Innate and adaptive immune responses in obliterative airway disease in rat tracheal allografts. J Heart Lung Transplant 2011; 30: 707-716.
45. Schwinzer R, Siefken R,. CD45RA+ and CD45RO+ T cells differ in susceptibility to cyclosporin A mediated inhibition of interleukin-2 production. Transpl Immunol 1996; 4: 61-63.